BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28043148)

  • 1. Analysis of differentially co-expressed genes based on microarray data of hepatocellular carcinoma.
    Wang Y; Jiang T; Li Z; Lu L; Zhang R; Zhang D; Wang X; Tan J
    Neoplasma; 2017; 64(2):216-221. PubMed ID: 28043148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential co-expression analysis of rheumatoid arthritis with microarray data.
    Wang K; Zhao L; Liu X; Hao Z; Zhou Y; Yang C; Li H
    Mol Med Rep; 2014 Nov; 10(5):2421-6. PubMed ID: 25118911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
    Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
    Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of hepatocellular carcinoma-associated hub genes and pathways by integrated microarray analysis.
    Liu F; Li H; Chang H; Wang J; Lu J
    Tumori; 2015; 101(2):206-14. PubMed ID: 25768320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms of pathogenesis in hepatocellular carcinoma revealed by RNA‑sequencing.
    Liu Y; Yang Z; Du F; Yang Q; Hou J; Yan X; Geng Y; Zhao Y; Wang H
    Mol Med Rep; 2017 Nov; 16(5):6674-6682. PubMed ID: 28901494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening and bioinformatics analysis of circular RNA expression profiles in hepatitis B-related hepatocellular carcinoma.
    Wang S; Cui S; Zhao W; Qian Z; Liu H; Chen Y; Lv F; Ding HG
    Cancer Biomark; 2018; 22(4):631-640. PubMed ID: 29914004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of key pathways in sorafenib-treated hepatocellular carcinoma based on a PCR-array.
    Liu Y; Wang P; Li S; Yin L; Shen H; Liu R
    Int J Clin Exp Pathol; 2015; 8(3):3027-35. PubMed ID: 26045814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of typical miRNAs and target genes in hepatocellular carcinoma by DNA microarray technique.
    He TL; Zheng KL; Li G; Song B; Zhang YJ
    Eur Rev Med Pharmacol Sci; 2014; 18(1):108-16. PubMed ID: 24452951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated network analysis to identify the key genes, transcription factors, and microRNAs involved in hepatocellular carcinoma.
    Shi SQ; Ke JJ; Xu QS; Wu WQ; Wan YY
    Neoplasma; 2018; 65(1):66-74. PubMed ID: 29322790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and interaction analysis of key genes and microRNAs in hepatocellular carcinoma by bioinformatics analysis.
    Mou T; Zhu D; Wei X; Li T; Zheng D; Pu J; Guo Z; Wu Z
    World J Surg Oncol; 2017 Mar; 15(1):63. PubMed ID: 28302149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression, regulation of DEN and HBx induced HCC mice models and comparisons of tumor, para-tumor and normal tissues.
    Tang Q; Wang Q; Zhang Q; Lin SY; Zhu Y; Yang X; Guo AY
    BMC Cancer; 2017 Dec; 17(1):862. PubMed ID: 29254483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and functional analysis of differentially expressed genes in poorly differentiated hepatocellular carcinoma using RNA-seq.
    Huang Y; Pan J; Chen D; Zheng J; Qiu F; Li F; Wu Y; Wu W; Huang X; Qian J
    Oncotarget; 2017 May; 8(22):35973-35983. PubMed ID: 28415592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinformatics analysis to identify the key genes affecting the progression and prognosis of hepatocellular carcinoma.
    Zhang Y; Wang S; Xiao J; Zhou H
    Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30705088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression profiling of human HBV- and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags.
    Yoon SY; Kim JM; Oh JH; Jeon YJ; Lee DS; Kim JH; Choi JY; Ahn BM; Kim S; Yoo HS; Kim YS; Kim NS
    Int J Oncol; 2006 Aug; 29(2):315-27. PubMed ID: 16820872
    [TBL] [Abstract][Full Text] [Related]  

  • 15.  CUL4B, NEDD4, and UGT1As involve in the TGF-β signalling in hepatocellular carcinoma.
    Qu Z; Li D; Xu H; Zhang R; Li B; Sun C; Dong W; Zhang Y
    Ann Hepatol; 2016; 15(4):568-76. PubMed ID: 27236156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of hepatocellular carcinoma tumorigenesis by curcumin may be associated with CDKN1A and CTGF.
    Zeng Y; Shen Z; Gu W; Wu M
    Gene; 2018 Apr; 651():183-193. PubMed ID: 29408622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatics analysis for hepatocellular carcinoma genes based on the data of expression profile chip.
    Xiao J; Zhang Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Sept 28; 45(9):1053-1060. PubMed ID: 33051418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of gene expression profiles identifies differential biomarkers for hepatocellular carcinoma and cholangiocarcinoma.
    Likhitrattanapisal S; Tipanee J; Janvilisri T
    Tumour Biol; 2016 Sep; 37(9):12755-12766. PubMed ID: 27448818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated analysis of long noncoding RNA expression profiles in lymph node metastasis of hepatocellular carcinoma.
    Ma J; Zhang L; Yang P; Zeng ZC; Xiang ZL
    Gene; 2018 Nov; 676():47-55. PubMed ID: 29981417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNAs and genes contributing to the generation of cancer stem cells in hepatocellular carcinoma identified by RNA sequencing analysis.
    Cao L; Zhang Q; Cheng S; Chen Z; Hua Z; Yang J; Liu D; Cui N
    Oncol Rep; 2016 Nov; 36(5):2619-2624. PubMed ID: 27667473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.